Current treatment approaches for brain metastases in ALK/ROS1/NTRK-positive non-small-cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current treatment approaches for brain metastases in ALK/ROS1/NTRK-positive non-small-cell lung cancer

Published:2022-12-29 Issue:1 Volume:23 Page:29-41
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Rossi Sabrina¹,Marinello Arianna²,Pagliaro Arianna²,Franceschini Davide³,Navarria Pierina³,Finocchiaro Giovanna¹,Toschi Luca¹,Scorsetti Marta²³,Santoro Armando¹²

Affiliation:

1. Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Milan, Italy

2. Department of Biomedical Sciences, Humanitas University, Milan, Italy

3. Department of Radiotherapy and Radiosurgery, IRCCS Humanitas Research Hospital, Milan, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2023.2162044

Reference123 articles.

1. Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers

2. EML4-ALK Variants: Biological and Molecular Properties, and the Implications for Patients

3. Blood-brain Barrier Remodeling during Brain Metastasis Formation

4. Brain metastases as preventive and therapeutic targets

5. The management of brain metastases

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: ALK D1225N missense mutation in lung adenocarcinoma responds to tyrosine kinase inhibitors;Frontiers in Pharmacology;2023-07-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP